483 Response Novartis Pharmaceuticals Sep 2001

Mariza Jafary FDA, Paula Trost FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - Vacaville, CA, United States facility and issued inspectional observation (via FDA 483) on 19 Sep 2001.

Product details

  • Category:
  • Inspection end: 19 Sep 2001
  • Location: Vacaville, United States
  • FEI: 3000215618
Add To Cart